Welcome to our dedicated page for Winmark SEC filings (Ticker: WINA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Winmark Corporation filings document disclosures for a public resale franchisor with established franchise brands and a related leasing business. Recent Form 8-K reports cover operating results, financial condition, cash dividends, franchise-system metrics, system-wide sales, point-of-sale software fee matters and the Plato’s Closet North American Ad Fund.
The company’s regulatory record also includes governance and shareholder-vote disclosures. Proxy and annual-meeting filings address board composition, director elections, advisory executive-compensation votes, auditor ratification, stock option plan matters and committee assignments, while material-event reports record board changes and related equity awards.
WINMARK CORP director Lawrence A. Barbetta reported a new compensation award of stock options. On 2026-06-01, he received a grant of 356 Non-Employee Director Stock Options to buy Winmark common stock at an exercise price of $378.57 per share, vesting 25% per year for four years and expiring on 2036-06-01. After this filing, he directly holds 649 shares of common stock and multiple option awards with various exercise prices and expiration dates.
WINMARK CORP director Amy C. Becker reported a new stock option grant and updated her existing option holdings. On 2026-06-01, she received a non-employee stock option covering 356 shares of common stock at an exercise price of $378.57 per share. The option becomes exercisable starting 2027-06-01 and expires on 2036-06-01, and a footnote states it vests 25% per year for four years.
The filing also lists previously granted non-employee stock options she continues to hold, including grants exercisable at $248.64 for 5,500 underlying shares expiring on 2032-11-15, and at $238.60 for 620 underlying shares expiring on 2032-12-12. The transactions disclosed are compensation-related option awards and holdings, with no open‑market purchases or sales of common stock reported.
Winmark Corp director Philip Irving Smith reported a new stock option grant and his existing option holdings. On the reported date, he received a non-employee stock option covering 356 shares of common stock at an exercise price of $378.57 per share, exercisable from June 1, 2027 until June 1, 2036. A footnote states these options vest 25% per year for four years, indicating a long-term incentive structure. The filing also lists several other non-employee stock options he holds directly, with exercise prices between $291.01 and $446.68 and individual grants ranging from 240 to 4,500 underlying shares, showing a meaningful ongoing equity-based compensation position.
Winmark Corp director Gina DeCaro Sprenger reported a new equity award. She received 356 Non-Employee Stock Options to buy Winmark common stock at an exercise price of $378.57 per share, vesting 25% per year for four years and expiring on June 1, 2036.
Following this filing, she directly holds 250 shares of common stock and multiple outstanding option grants, including one covering 10,000 underlying shares at an exercise price of $182.21 per share expiring on January 13, 2031. The transactions disclosed are compensation-related awards and holdings rather than open-market purchases or sales.
WINMARK CORP director Percy C. Tomlinson Jr. received a grant of 356 Non-Employee Stock Options to buy common stock at an exercise price of $378.57 per share. According to the footnote, the options vest 25% per year for four years starting on June 1, 2027.
After this grant, he holds 800 common shares directly and multiple outstanding option awards, including an option covering 5,400 underlying shares at a $242.58 exercise price expiring on December 14, 2031.
WINMARK CORP director Stephanie S. Hoppe reported a new stock option grant. She received 356 Non-Employee Stock Options to buy Common Stock at an exercise price of $378.57 per share, expiring on June 1, 2036, described as a grant, award, or other acquisition.
The options vest 25% per year for four years according to the footnote, indicating a multi‑year compensation structure rather than an open-market purchase. The filing also shows an existing Non-Employee Stock Option covering 3,400 underlying Common Stock shares at a $372.02 exercise price, expiring on May 5, 2036, which remains outstanding.
WINMARK CORP director Keith Credendino received a new stock option grant for 356 shares of common stock at an exercise price of $378.57 per share. The options are scheduled to vest at 25% per year over four years, aligning compensation with longer-term company performance.
After this grant, Credendino holds additional non-employee stock options that are exercisable into 256 shares at an exercise price of $444.54 and 3,000 shares at $393.64, both expiring in 2035. The new 2036-dated grant increases his overall equity-based incentive position without involving any open-market share purchases or sales in this filing.
WINMARK CORP’s chief financial officer Anthony D. Ishaug reported a new equity compensation award. On June 1, 2026 he received 2,420 Employee Stock Options, each giving the right to buy one share of common stock at an exercise price of $378.57.
These options vest at 25% per year for four years and are scheduled to expire on June 1, 2036, tying a portion of his pay to the company’s long‑term share performance. After the reported update, he directly holds 69,776 shares of common stock plus multiple earlier option grants with various exercise prices and expirations.
WINMARK CORP Chief Operating Officer Renae M. Gaudette reported an equity compensation update. The Form 4 shows a grant of 1,984 Employee Stock Options (right to buy Common Stock) at an exercise price of $378.57 per share, exercisable until an expiration date in 2036.
Following this grant, Gaudette directly holds 21,360 shares of Common Stock and a series of existing employee stock option awards with exercise prices ranging from about $122.50 to $444.54 and expirations extending through 2036. Most other line items reflect previously granted option holdings rather than new purchases or sales.
WINMARK CORP chair and CEO Brett D. Heffes reported a new grant of 4,620 employee stock options for common stock on June 1, 2026. The options have an exercise price of $378.57 per share, vest 25% per year for four years, and expire on June 1, 2036.
After this grant, Heffes holds 114,400 shares of common stock directly and 338 shares indirectly through a family office. He also retains multiple outstanding option awards with exercise prices between $176.20 and $444.54 per share and expiration dates from 2029 through 2036.